Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Total Non-Current Liabilities (2023 - 2024)

Mangoceuticals' Total Non-Current Liabilities history spans 2 years, with the latest figure at $12167.0 for Q3 2024.

  • For Q3 2024, Total Non-Current Liabilities fell 85.07% year-over-year to $12167.0; the TTM value through Sep 2024 reached $12167.0, down 85.07%, while the annual FY2023 figure was $64961.0, N/A changed from the prior year.
  • Total Non-Current Liabilities for Q3 2024 was $12167.0 at Mangoceuticals, down from $30117.0 in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $113267.0 in Q1 2023 and bottomed at $12167.0 in Q3 2024.